##gff-version 3
##sequence-region P47870 1 512
P47870	UniProtKB	Signal peptide	1	25	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
P47870	UniProtKB	Chain	26	512	.	.	.	ID=PRO_0000000459;Note=Gamma-aminobutyric acid receptor subunit beta-2	
P47870	UniProtKB	Topological domain	26	244	.	.	.	Note=Extracellular;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P47870	UniProtKB	Transmembrane	245	266	.	.	.	Note=Helical;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P47870	UniProtKB	Transmembrane	270	292	.	.	.	Note=Helical;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P47870	UniProtKB	Transmembrane	304	326	.	.	.	Note=Helical;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P47870	UniProtKB	Topological domain	327	489	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P47870	UniProtKB	Transmembrane	490	511	.	.	.	Note=Helical;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P47870	UniProtKB	Region	119	121	.	.	.	Note=Agonist binding;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P47870	UniProtKB	Region	179	181	.	.	.	Note=Agonist binding;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P47870	UniProtKB	Region	289	310	.	.	.	Note=Allosteric effector binding;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P47870	UniProtKB	Binding site	224	224	.	.	.	Note=Agonist;Ontology_term=ECO:0000250;evidence=ECO:0000250	
P47870	UniProtKB	Modified residue	441	441	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P63137	
P47870	UniProtKB	Glycosylation	32	32	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P47870	UniProtKB	Glycosylation	104	104	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P47870	UniProtKB	Glycosylation	173	173	.	.	.	Note=N-linked (GlcNAc...) asparagine;Ontology_term=ECO:0000255;evidence=ECO:0000255	
P47870	UniProtKB	Disulfide bond	160	174	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250	
P47870	UniProtKB	Alternative sequence	1	63	.	.	.	ID=VSP_038823;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19763268;Dbxref=PMID:19763268	
P47870	UniProtKB	Alternative sequence	360	397	.	.	.	ID=VSP_038825;Note=In isoform 2 and isoform 4. Missing;Ontology_term=ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:19763268,ECO:0000303|PubMed:7707873,ECO:0000303|PubMed:8264558;Dbxref=PMID:14702039,PMID:15489334,PMID:19763268,PMID:7707873,PMID:8264558	
P47870	UniProtKB	Alternative sequence	360	376	.	.	.	ID=VSP_038824;Note=In isoform 3. IFYKDIKQNGTQYRSLW->VNSEGKPSLLLKLMEEC;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19763268;Dbxref=PMID:19763268	
P47870	UniProtKB	Alternative sequence	377	512	.	.	.	ID=VSP_038828;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19763268;Dbxref=PMID:19763268	
P47870	UniProtKB	Alternative sequence	410	410	.	.	.	ID=VSP_038826;Note=In isoform 4. E->D;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19763268;Dbxref=PMID:19763268	
P47870	UniProtKB	Alternative sequence	411	512	.	.	.	ID=VSP_038827;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:19763268;Dbxref=PMID:19763268	
P47870	UniProtKB	Natural variant	79	79	.	.	.	ID=VAR_080712;Note=In IECEE2%3B unknown pathological significance. M->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:25124326,ECO:0000269|PubMed:29100083;Dbxref=dbSNP:rs606231468,PMID:25124326,PMID:29100083	
P47870	UniProtKB	Natural variant	244	244	.	.	.	ID=VAR_080713;Note=In IECEE2%3B unknown pathological significance. Y->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29100083;Dbxref=PMID:29100083	
P47870	UniProtKB	Natural variant	277	277	.	.	.	ID=VAR_080714;Note=In IECEE2%3B unknown pathological significance. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29100083;Dbxref=PMID:29100083	
P47870	UniProtKB	Natural variant	284	284	.	.	.	ID=VAR_080715;Note=In IECEE2%3B unknown pathological significance. T->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29100083;Dbxref=PMID:29100083	
P47870	UniProtKB	Natural variant	287	287	.	.	.	ID=VAR_080716;Note=In IECEE2%3B loss of localization to the cell membrane%3B retained intracellularly it affects the cell surface expression of the GABA receptor%3B decreased GABA receptor activity. T->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27789573;Dbxref=PMID:27789573	
P47870	UniProtKB	Natural variant	293	293	.	.	.	ID=VAR_080717;Note=In IECEE2%3B unknown pathological significance. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29100083;Dbxref=PMID:29100083	
P47870	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_080718;Note=In IECEE2%3B unknown pathological significance. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29100083;Dbxref=PMID:29100083	
P47870	UniProtKB	Natural variant	304	304	.	.	.	ID=VAR_080719;Note=In IECEE2%3B unknown pathological significance. A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29100083;Dbxref=PMID:29100083	
P47870	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_080720;Note=In IECEE2%3B unknown pathological significance. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:29100083;Dbxref=PMID:29100083	
P47870	UniProtKB	Mutagenesis	389	389	.	.	.	Note=Displays reduced current rundown following repeated receptor activation. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19763268;Dbxref=PMID:19763268	
P47870	UniProtKB	Sequence conflict	336	336	.	.	.	Note=Q->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
